These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 306344)

  • 1. Surface characteristics of lymphoma cells in relation to treatment, response and survival.
    Stathopoulos G; Kay HE; Hamlin IM; McKay AM
    Eur J Cancer (1965); 1978 May; 14(5):479-83. PubMed ID: 306344
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lymphocyte surface markers during treatment of non-Hodgkin's lymphomas].
    Trepińska E; Burchardt K
    Z Gesamte Inn Med; 1981 Sep; 36(18):681-2. PubMed ID: 6976047
    [No Abstract]   [Full Text] [Related]  

  • 3. Detection of intracellular and cell surface immunoglobulin in non-Hodgkin's lymphoma.
    Davey FR; Halliday D; Marucci AA; Gottlieb AJ
    Hum Pathol; 1978 May; 9(3):285-94. PubMed ID: 350755
    [No Abstract]   [Full Text] [Related]  

  • 4. Lymphocyte surface markers.
    Thomson AW
    Scott Med J; 1979 Apr; 24(2):118-20. PubMed ID: 315100
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical and prognostic significance of the T-B immunological classification of non-Hodgkin's lymphomas.
    Ogasawara H; Fujitani T; Mizojiri G; Hattori H
    Laryngoscope; 1981 Jan; 91(1):125-32. PubMed ID: 7005580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current views on the diagnosis of lymphomas by surface and cytoplasmic markers.
    Lewis RE; Johnson WW; Cruse JM
    Surv Immunol Res; 1982; 1(2):162-72. PubMed ID: 6314466
    [No Abstract]   [Full Text] [Related]  

  • 7. Current concepts in immunology: Cell-surface markers in lymphoproliferative disease.
    Aisenberg AC
    N Engl J Med; 1981 Feb; 304(6):331-6. PubMed ID: 6969365
    [No Abstract]   [Full Text] [Related]  

  • 8. Surface markers define human lymphoid malignancies with differing prognoses.
    Kersey J; Coccia P; Bloomfield C; Nesbit M; McKenna R; Brunning R; Hallgren H; Gajl-Peczalska K
    Haematol Blood Transfus; 1977; 20():17-24. PubMed ID: 305392
    [No Abstract]   [Full Text] [Related]  

  • 9. 'Double marker' lymphocytes in patients receiving tetracycline.
    Pudifin DJ; Duursma J; Formo R; Brain P
    Clin Exp Immunol; 1978 Oct; 34(1):143-4. PubMed ID: 312167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [T- and B-lymphocytes in lymphoproliferative diseases].
    Tsveibakh AS; Gol'dman EI
    Vopr Onkol; 1978; 24(1):11-6. PubMed ID: 305684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Surface markers of the lymphoid cells in non-Hodgkin's lymphoma].
    Płuzańska A; Polkowska-Kulesza E; Robak T; Kuźmicka J; Mazurowa A; Szadowska A; Woźniak L
    Acta Haematol Pol; 1980; 11(1):31-9. PubMed ID: 6966115
    [No Abstract]   [Full Text] [Related]  

  • 12. [Phenotype of the cells of malignant non-Hodgkin lymphoma with low degree malignancy determined by the studies of surface receptors].
    Urasiński I; Sochacka-Kuzko B; Krygier-Stojałowska A; Chosia M
    Pol Arch Med Wewn; 1982; 68(1-2):65-76. PubMed ID: 6984505
    [No Abstract]   [Full Text] [Related]  

  • 13. Stability of T- and B-cell numbers in human peripheral blood.
    Hofman FM; Kanesberg B; Smith D; Garrison D; Sevier ED
    Am J Clin Pathol; 1982 Jun; 77(6):710-3. PubMed ID: 6979921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface phenotyping, histology and the nature of non-Hodgkin lymphoma in 157 patients.
    Habeshaw JA; Catley PF; Stansfeld AG; Brearley RL
    Br J Cancer; 1979 Jul; 40(1):11-34. PubMed ID: 314300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocytic lymphoma simulating hairy cell leukemia: a consideration of reliable and unreliable diagnostic features.
    Palutke M; Tabaczka P; Mirchandani I; Goldfarb S
    Cancer; 1981 Nov; 48(9):2047-55. PubMed ID: 6975157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocyte responsiveness to mitogens and quantitation of T and B lymphocytes in canine malignant lymphoma.
    Dutta SK; Novilla MN; Bumgardner MK; Ingling A
    Am J Vet Res; 1978 Mar; 39(3):455-8. PubMed ID: 305738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell surface phenotype in lymphoproliferative disease.
    Aisenberg AC; Wilkes BM; Long JC; Harris NL
    Am J Med; 1980 Feb; 68(2):206-13. PubMed ID: 6965562
    [No Abstract]   [Full Text] [Related]  

  • 18. Malignant lymphomas as tumours of the immune system.
    Berard CW; Cossman J; Jaffe ES
    Br J Cancer; 1980 Jul; 42(1):1-20. PubMed ID: 7000112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of T and B cell populations in some lymphoproliferative disorders.
    Herzog P; Stöckbauer P
    Czech Med; 1980; 3(4):263-70. PubMed ID: 6971744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lukes-Collins classification and its significance.
    Lukes RJ; Collins RD
    Cancer Treat Rep; 1977 Sep; 61(6):971-9. PubMed ID: 302740
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.